Honya Biotech is proud to announce the successful deployment of Western Australia’s first Honya high-throughput oligonucleotide synthesis system, marking a significant milestone in the company’s expansion across the Asia-Pacific life science market.
The new system was commissioned at the facilities of Syngenis, our local partner in Australia. Over the past week, Honya Biotech’s technical team completed on-site installation, validation, and hands-on training with the Syngenis team, ensuring the platform is fully operational and ready to support advanced nucleic acid research.
Providing cutting-edge technology to accelerate genomic innovation.
The Honya series delivers high-throughput, high-quality oligonucleotide synthesis for applications ranging from genomics and diagnostics to therapeutics development. With this installation, Australian research institutions and biotech partners gain localized access to reliable, scalable synthesis technology backed by Honya Biotech’s global technical support.
Honya Biotech specializes in the R&D, manufacturing, and sales of nucleic acid synthesis instruments, reagents, consumables, and raw materials. The company remains committed to empowering life science research worldwide through continuous innovation and customer-focused service.
Post time: Nov-09-2026